Cargando…

Urinary epidermal growth factor as a prognostic marker for the progression of Alport syndrome in children

BACKGROUND: Alport syndrome is a rare hereditary kidney disease manifested with progressive renal failure. Considerable variation exists in terms of disease progression among patients with Alport syndrome. Identification of patients at high risk of rapid progression remains an unmet need. Urinary ep...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Baihong, Zhang, Yanqin, Wang, Fang, Nair, Viji, Ding, Fangrui, Xiao, Huijie, Yao, Yong, Kretzler, Matthias, Ju, Wenjun, Ding, Jie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2018
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6132884/ https://www.ncbi.nlm.nih.gov/pubmed/29948307 http://dx.doi.org/10.1007/s00467-018-3988-1

Ejemplares similares

Urinary Epidermal Growth Factor as a Marker of Disease Progression in Children With Nephrotic Syndrome
por: Gipson, Debbie S., et al.
Publicado: (2019)

Intraindividual variations of urinary biomarkers in hospitalized children with glomerular diseases: a prospective observational study
por: Zhou, Jianmei, et al.
Publicado: (2023)

Mammalian Target of Rapamycin Complex 2 Signaling Pathway Regulates Transient Receptor Potential Cation Channel 6 in Podocytes
por: Ding, Fangrui, et al.
Publicado: (2014)

Calpain-Mediated Cleavage of Calcineurin in Puromycin Aminonucleoside-Induced Podocyte Injury
por: Ding, Fangrui, et al.
Publicado: (2016)

Effect of heterozygous pathogenic COL4A3 or COL4A4 variants on patients with X‐linked Alport syndrome
por: Zhang, Yanqin, et al.
Publicado: (2019)

Urinary Epidermal Growth Factor/Creatinine Ratio and Graft Failure in Renal Transplant Recipients: A Prospective Cohort Study
por: Yepes-Calderón, Manuela, et al.
Publicado: (2019)

Urinary epidermal growth factor predicts complete remission of proteinuria in Chinese children with IgA nephropathy
por: Zhou, Jianmei, et al.
Publicado: (2023)

Assessment of Fibrinogen-like 2 (FGL2) in Human Chronic Kidney Disease through Transcriptomics Data Analysis
por: Denicolò, Sara, et al.
Publicado: (2022)

Cyclosporine A protects podocytes by regulating WAVE1 phosphorylation
por: Li, Xuejuan, et al.
Publicado: (2015)

The Expression Profile of Complement Components in Podocytes
por: Li, Xuejuan, et al.
Publicado: (2016)

Integrating Automated Workflows, Human Intelligence and Collaboration
por: Mirel, Barbara, et al.
Publicado: (2009)

Genotype–phenotype correlations and nephroprotective effects of RAAS inhibition in patients with autosomal recessive Alport syndrome
por: Zhang, Yanqin, et al.
Publicado: (2021)

mRNA analysis identifies deep intronic variants causing Alport syndrome and overcomes the problem of negative results of exome sequencing
por: Wang, Xiaoyuan, et al.
Publicado: (2021)

Clinical practice recommendations for the treatment of Alport syndrome: a statement of the Alport Syndrome Research Collaborative
por: Kashtan, Clifford E., et al.
Publicado: (2012)

Urinary Monocyte Chemoattractant Protein-1 in Patients With Alport Syndrome
por: Kashtan, Clifford, et al.
Publicado: (2022)

Author Correction: mRNA analysis identifies deep intronic variants causing Alport syndrome and overcomes the problem of negative results of exome sequencing
por: Wang, Xiaoyuan, et al.
Publicado: (2021)

Alport Syndrome With Kidney Cysts Is Still Alport Syndrome
por: Savige, Judy, et al.
Publicado: (2021)

Endoplasmic Reticulum Stress Activation in Alport Syndrome Varies Between Genotype and Cell Type
por: Wang, Cong, et al.
Publicado: (2020)

Progressive Posterior Lenticonus in a Patient with Alport Syndrome
por: Al-Mahmood, Ammar M., et al.
Publicado: (2010)

X-linked Alport syndrome: pathogenic variant features and further auditory genotype-phenotype correlations in males
por: Zhang, Xiao, et al.
Publicado: (2018)

Advances and unmet needs in genetic, basic and clinical science in Alport syndrome: report from the 2015 International Workshop on Alport Syndrome
por: Gross, Oliver, et al.
Publicado: (2017)

The 2014 International Workshop on Alport Syndrome
por: Miner, Jeffrey H, et al.
Publicado: (2014)

Organoprotective Effects of Spironolactone on Top of Ramipril Therapy in a Mouse Model for Alport Syndrome
por: Rubel, Diana, et al.
Publicado: (2021)

Women and Alport syndrome
por: Rheault, Michelle N.
Publicado: (2011)

Alport's Syndrome in Pregnancy
por: Mehta, Suchita, et al.
Publicado: (2013)

Increasing urinary podocyte mRNA excretion and progressive podocyte loss in kidney contribute to the high risk of long-term renal disease caused by preterm birth
por: Ding, Fangrui, et al.
Publicado: (2021)

The association of urinary epidermal growth factors with ADPKD disease severity and progression
por: Harskamp, Laura R, et al.
Publicado: (2023)

Genotype‐phenotype correlation and prognostic impact in Chinese patients with Alport Syndrome
por: Shang, Shunlai, et al.
Publicado: (2019)

Ratio of Urinary Proteins to Albumin Excretion Shifts Substantially during Progression of the Podocytopathy Alport Syndrome, and Spot Urine Is a Reliable Method to Detect These Pathologic Changes
por: Boeckhaus, Jan, et al.
Publicado: (2023)

Molecular and Cellular Mechanisms Underlying the Initiation and Progression of Alport Glomerular Pathology
por: Cosgrove, Dominic, et al.
Publicado: (2022)

Sindrome de Alport : revisión bibliográfica
por: Velasco Bello, Fernando Mario
Publicado: (1994)

The Prediction of Key Cytoskeleton Components Involved in Glomerular Diseases Based on a Protein-Protein Interaction Network
por: Ding, Fangrui, et al.
Publicado: (2016)

The 2019 and 2021 International Workshops on Alport Syndrome
por: Daga, Sergio, et al.
Publicado: (2022)

Alport syndrome: facts and opinions
por: Kashtan, Clifford
Publicado: (2017)

Genetic diagnosis of Alport syndrome
por: Cheong, Hae Il
Publicado: (2019)

Alport Syndrome Classification and Management
por: Warady, Bradley A., et al.
Publicado: (2020)

Novel Therapies for Alport Syndrome
por: Chavez, Efren, et al.
Publicado: (2022)

Auditory Perception in Alport’s Syndrome
por: Viveiros, Carla Mherlyn, et al.
Publicado: (2015)

An overlap of Alport syndrome and rheumatoid arthritis in a patient and literature review
por: Tang, Xiaofei, et al.
Publicado: (2019)

Establishment and validation of a prognostic nomogram for extrahepatic cholangiocarcinoma
por: Zhao, Fangrui, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_9g17k01n9a1cun5hcvedscs216